Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Psycho-Oncology | 3 | 2026 | 5 | 1.290 |
Why?
|
| Refugees | 1 | 2025 | 8 | 0.900 |
Why?
|
| Psychological Trauma | 1 | 2025 | 11 | 0.900 |
Why?
|
| Cancer Survivors | 1 | 2025 | 108 | 0.790 |
Why?
|
| Telemedicine | 1 | 2025 | 253 | 0.670 |
Why?
|
| Healthcare Disparities | 1 | 2025 | 547 | 0.560 |
Why?
|
| Neoplasms | 3 | 2025 | 3348 | 0.360 |
Why?
|
| Health Services Accessibility | 2 | 2026 | 533 | 0.320 |
Why?
|
| Ukraine | 1 | 2025 | 27 | 0.230 |
Why?
|
| Sexual Dysfunctions, Psychological | 2 | 2016 | 37 | 0.220 |
Why?
|
| Health Status | 2 | 2004 | 388 | 0.200 |
Why?
|
| Quality of Life | 7 | 2015 | 1899 | 0.190 |
Why?
|
| Caregivers | 2 | 2002 | 200 | 0.190 |
Why?
|
| Social Class | 1 | 2003 | 156 | 0.180 |
Why?
|
| Bone Marrow Transplantation | 1 | 2001 | 286 | 0.160 |
Why?
|
| Prostatic Neoplasms | 4 | 2004 | 1842 | 0.150 |
Why?
|
| Hematologic Neoplasms | 2 | 2002 | 383 | 0.140 |
Why?
|
| Adult | 7 | 2025 | 29587 | 0.130 |
Why?
|
| Female | 11 | 2026 | 51756 | 0.120 |
Why?
|
| Gynecological Examination | 1 | 2016 | 19 | 0.120 |
Why?
|
| Clinical Competence | 1 | 2021 | 867 | 0.110 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2016 | 77 | 0.110 |
Why?
|
| Aged, 80 and over | 3 | 2025 | 7418 | 0.110 |
Why?
|
| Aged | 9 | 2025 | 21844 | 0.100 |
Why?
|
| Humans | 16 | 2026 | 98362 | 0.100 |
Why?
|
| Adolescent | 4 | 2025 | 10137 | 0.100 |
Why?
|
| Self Report | 1 | 2015 | 357 | 0.090 |
Why?
|
| Veterans | 2 | 2004 | 119 | 0.090 |
Why?
|
| Middle Aged | 9 | 2025 | 29532 | 0.090 |
Why?
|
| Young Adult | 1 | 2025 | 7568 | 0.090 |
Why?
|
| Male | 10 | 2025 | 47257 | 0.070 |
Why?
|
| Curriculum | 2 | 2026 | 636 | 0.070 |
Why?
|
| Patient Participation | 3 | 2004 | 250 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 3 | 1999 | 1088 | 0.060 |
Why?
|
| Surveys and Questionnaires | 4 | 2003 | 3032 | 0.060 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2003 | 50 | 0.050 |
Why?
|
| United States | 3 | 2026 | 8258 | 0.050 |
Why?
|
| Medical Oncology | 1 | 2026 | 423 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2026 | 687 | 0.040 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2002 | 168 | 0.040 |
Why?
|
| Karnofsky Performance Status | 1 | 2001 | 43 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2002 | 202 | 0.040 |
Why?
|
| Mood Disorders | 1 | 2001 | 87 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2021 | 181 | 0.040 |
Why?
|
| Decision Support Techniques | 1 | 2002 | 194 | 0.040 |
Why?
|
| Consensus | 1 | 2021 | 309 | 0.040 |
Why?
|
| Comorbidity | 1 | 2003 | 1035 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2003 | 419 | 0.040 |
Why?
|
| Transplantation, Homologous | 1 | 2001 | 1027 | 0.040 |
Why?
|
| Sexually Transmitted Diseases, Viral | 1 | 1997 | 4 | 0.030 |
Why?
|
| Sexually Transmitted Diseases, Bacterial | 1 | 1997 | 4 | 0.030 |
Why?
|
| Sulfates | 1 | 1997 | 38 | 0.030 |
Why?
|
| Carbohydrates | 1 | 1997 | 40 | 0.030 |
Why?
|
| Sex Factors | 1 | 2001 | 1142 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2001 | 384 | 0.030 |
Why?
|
| Herpesvirus 2, Human | 1 | 1996 | 21 | 0.030 |
Why?
|
| Survival Rate | 2 | 2016 | 2050 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2002 | 977 | 0.030 |
Why?
|
| Heparin | 1 | 1996 | 182 | 0.030 |
Why?
|
| Oncologists | 1 | 2016 | 43 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2003 | 4044 | 0.030 |
Why?
|
| Physical Examination | 1 | 2016 | 149 | 0.030 |
Why?
|
| Herpesvirus 1, Human | 1 | 1996 | 210 | 0.030 |
Why?
|
| Gynecology | 1 | 2016 | 135 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2016 | 417 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 1996 | 2017 | 0.020 |
Why?
|
| Attitude to Health | 2 | 2004 | 217 | 0.020 |
Why?
|
| Radiotherapy | 2 | 2002 | 325 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1999 | 2661 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2004 | 9770 | 0.020 |
Why?
|
| Diet | 2 | 1999 | 469 | 0.010 |
Why?
|
| Nausea | 1 | 2004 | 95 | 0.010 |
Why?
|
| Sexuality | 1 | 2004 | 40 | 0.010 |
Why?
|
| Vomiting | 1 | 2004 | 109 | 0.010 |
Why?
|
| Combined Modality Therapy | 2 | 1999 | 1752 | 0.010 |
Why?
|
| Weight Gain | 1 | 2004 | 138 | 0.010 |
Why?
|
| Observation | 1 | 2002 | 38 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2002 | 155 | 0.010 |
Why?
|
| Markov Chains | 1 | 2002 | 147 | 0.010 |
Why?
|
| Probability | 1 | 2002 | 356 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2002 | 1195 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2002 | 970 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2004 | 580 | 0.010 |
Why?
|
| Prostatectomy | 1 | 2002 | 491 | 0.010 |
Why?
|
| Decision Making | 1 | 2004 | 689 | 0.010 |
Why?
|
| Patient Selection | 1 | 2002 | 722 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 1945 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2004 | 2056 | 0.010 |
Why?
|
| Chlamydia trachomatis | 1 | 1997 | 15 | 0.010 |
Why?
|
| Neisseria gonorrhoeae | 1 | 1997 | 18 | 0.010 |
Why?
|
| Bacterial Adhesion | 1 | 1997 | 84 | 0.010 |
Why?
|
| Gonorrhea | 1 | 1997 | 24 | 0.010 |
Why?
|
| Chlamydia Infections | 1 | 1997 | 30 | 0.010 |
Why?
|
| Herpes Simplex | 1 | 1997 | 79 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2002 | 2085 | 0.010 |
Why?
|
| Hospitalization | 1 | 2002 | 988 | 0.010 |
Why?
|
| Speech Disorders | 1 | 1996 | 18 | 0.010 |
Why?
|
| Serotyping | 1 | 1996 | 28 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1997 | 520 | 0.010 |
Why?
|
| Vero Cells | 1 | 1996 | 100 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 1997 | 214 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 1997 | 326 | 0.010 |
Why?
|
| Body Image | 1 | 1996 | 87 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 1999 | 301 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1996 | 427 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 1997 | 525 | 0.010 |
Why?
|
| Interpersonal Relations | 1 | 1996 | 182 | 0.010 |
Why?
|
| Smoking | 1 | 1999 | 676 | 0.010 |
Why?
|
| Temperature | 1 | 1996 | 442 | 0.010 |
Why?
|
| Prognosis | 1 | 2002 | 4126 | 0.010 |
Why?
|
| Feeding and Eating Disorders | 1 | 1996 | 190 | 0.010 |
Why?
|
| Emotions | 1 | 1996 | 387 | 0.010 |
Why?
|
| Depression | 1 | 1997 | 619 | 0.010 |
Why?
|
| Risk Factors | 1 | 2002 | 6271 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1999 | 4817 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2002 | 3285 | 0.000 |
Why?
|
| HIV Infections | 1 | 1997 | 1018 | 0.000 |
Why?
|
| Animals | 1 | 1996 | 28981 | 0.000 |
Why?
|